Photo by dawson2406 from unsplash
Sexual dysfunction is common among patients with major depressive disorder (MDD). In the CLARITY study, the safety and efficacy of adjunctive pimavanserin, an inverse agonist at 5‐HT2A receptors, were demonstrated… Click to show full abstract
Sexual dysfunction is common among patients with major depressive disorder (MDD). In the CLARITY study, the safety and efficacy of adjunctive pimavanserin, an inverse agonist at 5‐HT2A receptors, were demonstrated when added to existing treatment for MDD. This analysis provides a detailed assessment of the effects of pimavanserin on sexual function from the CLARITY study.
Keywords:
analysis;
adjunctive pimavanserin;
treatment mdd
Journal Title: Depression and Anxiety
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Depression and Anxiety
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!